Department of Epidemiology, Geisel School of Medicine at Dartmouth College, Hanover, NH.
Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA.
Am J Obstet Gynecol. 2018 Apr;218(4):433.e1-433.e10. doi: 10.1016/j.ajog.2017.12.223. Epub 2017 Dec 29.
Singleton infants conceived using assisted reproductive technology have lower average birthweights than naturally conceived infants and are more likely to be born low birthweight (<2500 gr). Lower birthweights are associated with increased infant and child mortality and poor adult health outcomes, including cardiovascular disease, hypertension, and diabetes. Data from registry and single-center studies suggest that frozen/thawed embryo transfer may be associated with larger birthweights. To date, however, a nationwide, full-population study on United States infants born using frozen/thawed embryo transfer has not been reported.
The objective of this study was to compare the effect of frozen/thawed vs fresh embryo transfer on birthweight outcomes for singleton, term infants conceived using in vitro fertilization in the United States between 2007 and 2014, including average birthweight and the risks of both macrosomia (>4000 g) and low birthweight (<2500 g).
We used data from the Centers for Disease Control and Prevention's National Assisted Reproductive Technology Surveillance System to compare birthweight outcomes of live-born singleton, autologous oocyte, term (37-43 weeks) infants. Generalized linear models for all infants and stratified by infant sex were used to assess the relationship between frozen/thawed embryo transfer and birthweight, in grams. Infertility diagnosis, year of treatment, maternal age, maternal obstetric history, maternal and paternal race, and infant gestational age and sex were included in the models. Missing race data were imputed. The adjusted relative risks for macrosomia and low birthweight were evaluated using multivariable predicted marginal proportions from logistic regression models.
In total, 180,184 singleton, term infants were included, with 55,898 (31.02%) having been conceived from frozen/thawed embryos. Frozen/thawed embryo transfer was associated with, on average, a 142 g increase in birthweight compared with infants born after fresh embryo transfer (P < .001). An interaction between infant sex and embryo transfer type was significant (P < .0001), with frozen/thawed embryo transfer having a larger effect on male infants by 16 g. The adjusted risk of a macrosomic infant was 1.70 times higher (95% confidence interval, 1.64-1.76) following frozen/thawed embryo transfer than fresh embryo transfer. However, adjusted risk of low birthweight following frozen/thawed embryo transfer was 0.52 (95% confidence interval, 0.48-0.56) compared with fresh embryo transfer.
Frozen/thawed embryo transfer, in comparison with fresh embryo transfer, was associated with increased average birthweight in singleton, autologous oocytes, term infants born in the United States, with a significant interaction between frozen/thawed embryo transfer and infant sex. The risk of macrosomia following frozen/thawed embryo transfer was greater than that following fresh embryo transfer, but the risk of low birthweight among frozen/thawed embryo transfer infants was significantly decreased in comparison with fresh embryo transfer infants.
通过辅助生殖技术受孕的单胎婴儿的平均出生体重低于自然受孕的婴儿,而且更有可能出生体重低(<2500 克)。较低的出生体重与婴儿和儿童死亡率增加以及成年后健康状况不佳有关,包括心血管疾病、高血压和糖尿病。来自登记处和单中心研究的数据表明,冷冻/解冻胚胎移植可能与更大的出生体重有关。然而,迄今为止,在美国还没有关于使用冷冻/解冻胚胎移植的婴儿的全国性、全人群研究报告。
本研究旨在比较冷冻/解冻与新鲜胚胎移植对 2007 年至 2014 年间美国通过体外受精受孕的单胎、足月婴儿出生体重结局的影响,包括平均出生体重以及巨大儿(>4000 克)和低出生体重(<2500 克)的风险。
我们使用疾病控制与预防中心国家辅助生殖技术监测系统的数据,比较了活产单胎、自体卵母细胞、足月(37-43 周)婴儿的出生体重结局。使用广义线性模型对所有婴儿和按婴儿性别分层,评估冷冻/解冻胚胎移植与出生体重(克)的关系。模型中纳入了不孕诊断、治疗年份、产妇年龄、产妇产科史、产妇和父亲种族以及婴儿胎龄和性别。缺失的种族数据被推断。使用多变量预测边际比例的逻辑回归模型评估巨大儿和低出生体重的调整相对风险。
共纳入 180184 例单胎足月婴儿,其中 55898 例(31.02%)为冷冻/解冻胚胎受孕。与新鲜胚胎移植后出生的婴儿相比,冷冻/解冻胚胎移植平均增加 142 克出生体重(P<0.001)。婴儿性别和胚胎移植类型之间的交互作用具有统计学意义(P<0.0001),冷冻/解冻胚胎移植对男婴的影响更大,增加 16 克。与新鲜胚胎移植相比,冷冻/解冻胚胎移植后巨大儿的调整风险高 1.70 倍(95%置信区间,1.64-1.76)。然而,与新鲜胚胎移植相比,冷冻/解冻胚胎移植后出生体重低的调整风险为 0.52(95%置信区间,0.48-0.56)。
与新鲜胚胎移植相比,冷冻/解冻胚胎移植与美国单胎、自体卵母细胞、足月婴儿的平均出生体重增加有关,冷冻/解冻胚胎移植与婴儿性别之间存在显著的交互作用。冷冻/解冻胚胎移植后巨大儿的风险大于新鲜胚胎移植后,但冷冻/解冻胚胎移植婴儿的低出生体重风险明显低于新鲜胚胎移植婴儿。